BRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza

Reuters12-20

Dec 20 (Reuters) - Zivo Bioscience Inc ZIVO.PK:

ZIVO BIOSCIENCE REPORTS PRELIMINARY EFFICACY OF ITS PROPRIETARY ACTIVE INGREDIENTS IN THE BATTLE AGAINST AVIAN INFLUENZA
ZIVO BIOSCIENCE INC - STUDY SHOWS REDUCTION IN VIRAL TITERS IN INFECTED BIRDS
ZIVO BIOSCIENCE: STUDY SHOWED DELAY IN TRANSMISSION OF LPAI WHEN HEALTHY BIRDS WERE EXPOSED TO INFECTED BIRDS

Source text: ID:nBw6kzFh7a

Further company coverage: ZIVO.PK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492441959?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-20 22:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492441959","market":"us","top_or_hot":-1,"title":"BRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza</title></head><body><p><span>Dec 20 (Reuters)</span><span> - </span>Zivo Bioscience Inc <span>ZIVO.PK</span>:</p><ul><li><p>ZIVO BIOSCIENCE REPORTS PRELIMINARY EFFICACY OF ITS PROPRIETARY ACTIVE INGREDIENTS IN THE BATTLE AGAINST AVIAN INFLUENZA</p></li><li><p>ZIVO BIOSCIENCE INC - STUDY SHOWS REDUCTION IN VIRAL TITERS IN INFECTED BIRDS</p></li><li><p>ZIVO BIOSCIENCE: STUDY SHOWED DELAY IN TRANSMISSION OF LPAI WHEN HEALTHY BIRDS WERE EXPOSED TO INFECTED BIRDS</p></li></ul><p>Source text: <span>ID:nBw6kzFh7a</span></p><p>Further company coverage: <span>ZIVO.PK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-20 22:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUA3FZH10:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian InfluenzaDec 20 (Reuters) - Zivo Bioscience Inc ZIVO.PK:ZIVO BIOSCIENCE REPORTS ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUA3FZH10:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZIVO","symbol_name":"Zivo Bioscience, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUA3FZH10:1","article_id":"2492441959","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492441959","pubTimestamp":1734705136,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian InfluenzaDec 20 (Reuters) - Zivo Bioscience Inc ZIVO.PK:ZIVO BIOSCIENCE REPORTS PRELIMI","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZIVO":"Zivo Bioscience, Inc.","BK4183":"个人用品"},"translate_title":"简介-Zivo Bioscience报告其专有活性成分在对抗禽流感方面的初步功效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZIVO":0.9},"content_text":"BRIEF-Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian InfluenzaDec 20 (Reuters) - Zivo Bioscience Inc ZIVO.PK:ZIVO BIOSCIENCE REPORTS PRELIMINARY EFFICACY OF ITS PROPRIETARY ACTIVE INGREDIENTS IN THE BATTLE AGAINST AVIAN INFLUENZAZIVO BIOSCIENCE INC - STUDY SHOWS REDUCTION IN VIRAL TITERS IN INFECTED BIRDSZIVO BIOSCIENCE: STUDY SHOWED DELAY IN TRANSMISSION OF LPAI WHEN HEALTHY BIRDS WERE EXPOSED TO INFECTED BIRDSSource text: ID:nBw6kzFh7aFurther company coverage: ZIVO.PK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492441959"}